Csókay B - Search Results

1

Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression.

Eid H, Bodrogi I, Csókay B, Oláh E, Bak M. Eid H, et al. Among authors: csokay b. Anticancer Res. 1996 Nov-Dec;16(6B):3447-52. Anticancer Res. 1996. PMID: 9042205

2

[Multidrug resistance of testicular cancers. (Detection of P-glycoprotein and MDR1 gene expression and their clinical connection)].

Bak M, Hanna E, Csókay B, Bodrogi I, Oláh E. Bak M, et al. Among authors: csokay b. Orv Hetil. 1995 Jan 1;136(1):19-25. Orv Hetil. 1995. PMID: 7845662 Clinical Trial. Hungarian.

3

Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.

Olah E, Csokay B, Prajda N, Kote-Jarai Z, Yeh YA, Weber G. Olah E, et al. Among authors: csokay b. Anticancer Res. 1996 Sep-Oct;16(5A):2469-77. Anticancer Res. 1996. PMID: 8917337

4

Sequence alterations can mask each other's presence during screening with SSCP or heteroduplex analysis: BRCA genes as examples.

Orban TI, Csokay B, Olah E. Orban TI, et al. Among authors: csokay b. Biotechniques. 2000 Jul;29(1):94-8. doi: 10.2144/00291st04. Biotechniques. 2000. PMID: 10907083 Free article.

5

Molecular mechanisms in the antiproliferative action of quercetin.

Csokay B, Prajda N, Weber G, Olah E. Csokay B, et al. Life Sci. 1997;60(24):2157-63. doi: 10.1016/s0024-3205(97)00230-0. Life Sci. 1997. PMID: 9188758

6

High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.

Csokay B, Udvarhelyi N, Sulyok Z, Besznyak I, Ramus S, Ponder B, Olah E. Csokay B, et al. Cancer Res. 1999 Mar 1;59(5):995-8. Cancer Res. 1999. PMID: 10070953

7

Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online.

Csokay B, Tihomirova L, Stengrevics A, Sinicka O, Olah E. Csokay B, et al. Hum Mutat. 1999;14(1):92. doi: 10.1002/(sici)1098-1004(1999)14:1<92::aid-humu23>3.0.co;2-2. Hum Mutat. 1999. PMID: 10447273

8

Oncogene patterns in breast and ovarian carcinomas.

Csókay B, Papp J, Besznyák I, Bösze P, Sárosi Z, Tóth J, Zalay Z, Oláh E. Csókay B, et al. Eur J Surg Oncol. 1993 Dec;19(6):593-9. Eur J Surg Oncol. 1993. PMID: 7903645

9

Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.

Papp J, Csokay B, Bosze P, Zalay Z, Toth J, Ponder B, Olah E. Papp J, et al. Among authors: csokay b. Br J Cancer. 1996 Nov;74(10):1592-7. doi: 10.1038/bjc.1996.594. Br J Cancer. 1996. PMID: 8932340 Free PMC article.

10

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E. Van Der Looij M, et al. Among authors: csokay b. Int J Cancer. 2000 Jun 1;86(5):737-40. doi: 10.1002/(sici)1097-0215(20000601)86:5<737::aid-ijc21>3.0.co;2-1. Int J Cancer. 2000. PMID: 10797299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters